Cefazaflur
Cefazaflur is a cephalosporin antibiotic that is used in the treatment of various bacterial infections. It belongs to the third generation of cephalosporins and is known for its broad-spectrum activity against a wide range of bacteria.
Mechanism of Action[edit]
Cefazaflur works by inhibiting the synthesis of the bacterial cell wall. It binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall. This binding leads to the inhibition of the third and last stage of bacterial cell wall synthesis, which ultimately causes cell lysis.
Pharmacokinetics[edit]
After oral administration, Cefazaflur is rapidly absorbed from the gastrointestinal tract. It is widely distributed in body tissues and fluids. The drug is primarily excreted unchanged in the urine.
Clinical Uses[edit]
Cefazaflur is used to treat a variety of bacterial infections, including those caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. It is also effective against certain Gram-negative bacteria, such as Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.
Side Effects[edit]
Common side effects of Cefazaflur include nausea, vomiting, diarrhea, and abdominal pain. In rare cases, it can cause serious side effects like allergic reactions, kidney damage, and blood disorders.
Contraindications[edit]
Cefazaflur is contraindicated in patients with a known allergy to cephalosporin antibiotics. It should be used with caution in patients with a history of kidney disease or gastrointestinal disease.
Drug Interactions[edit]
Cefazaflur may interact with other drugs like probenecid, warfarin, and aminoglycosides. Therefore, it is important to inform the healthcare provider about all the medications being taken before starting treatment with Cefazaflur.
- Cefaclor (2nd)
- Cefadroxil (1st)
- Cefdinir (3rd)
- Cefditoren (3rd)
- Cefixime (3rd)
- Cefpodoxime (3rd)
- Cefprozil (2nd)
- Ceftibuten (1st)
- Cephalexin (1st)
- Cefuroxime (2nd)
- Cephradine (1st)
- Loracarbef (2nd)
- Cefazolin (1st)
- Cefepime (4th)
- Cefoperazone (3rd)
- Cefotaxime (3rd)
- Cefoxitin (2nd)
- Ceftaroline (5th)
- Ceftazidime (3rd)
- Ceftibuten (3rd)
- Ceftizoxime (3rd)
- Ceftolozane/Tazobactam (5th)
- Cefuroxime (2nd)
- Cephradine (1st)
- Ceftriaxone (3rd)
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
